TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Advance Purchase Agreement

Vaccines
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Business Energy and Industrial Strategy: "Advance Purchase Agreement". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBusiness Energy and Industrial StrategyScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Business Energy and Industrial Strategy
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Business Energy and Industrial Strategy. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.1Bids / Report
64% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 26 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBusiness Energy and Industrial Strategy
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 Oct 2021, 16:33 BST
Last source update20 Oct 2021, 16:33 BST
Recurring procurementNot published
ClassificationVaccines
Delivery area
UK
OCIDocds-h6vhtk-02ee22
What is being bought
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
What changed
From the official release history
  1. Status changed to complete
    20 Oct 2021, 16:33 BST
  2. Official notice release published
    20 Oct 2021, 16:33 BST
  3. Buyer information updated
    20 Oct 2021, 16:33 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Procurement of the Covid-19 Adjuvanted Pandemic Vaccine. Additional information: Contract value is being withheld due to commercial sensitivity (PCR 2015 Reg 50(6)(b) and (c) and FOIA 2000 Section 43). Publication may enable competitors to calculate cost per dose. This will commercially prejudice: (i) the supplier in its negotiations with other national governments; and (ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 Oct 2021, 16:33 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 20 Sept 2021, 00:00 BST · £1
Commercial outcome and competition
Awards
Aventis Pharma Ltd, GlaxoSmithKline Biologicals S.A
Not published · Not published · active
Contracts
Advance Purchase Agreement
£1 · signed 20 Sept 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

Business Energy and Industrial Strategy

Contracting authority GB-FTS-5606
View buyer profile

  • Business Energy and Industrial Strategy
    buyer

    1 Victoria Street, London, UKI32, SW1H0ET
    VTFContracts@beis.gov.uk

  • Aventis Pharma Ltd
    supplier

    Thames Valley Park Drive, Reading, Berkshire, UK, RG6 1PT

  • Department of Business, Energy and Industrial Strategy
    reviewBody

    1 Victoria Street, Westminister, London, SW1H 0ET

  • GlaxoSmithKline Biologicals S.A
    supplier

    Rue de l'Institut 89, Rixensart, BE, B-1330
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe award of the contract to Aventis Pharma and GSK is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii). Furthermore, this Advance Purchase Agreement is the execution of the previous Capacity Reservation Agreement (Please see linked notice)